CORDLIFE GROUP

More
8 years 6 months ago - 8 years 6 months ago #22706 by Kapitan
Replied by Kapitan on topic CORDLIFE GROUP
Holy cow! Cordlife jumped over the moon, with a 10 cent rise to $1.32.

Most interestingly:

12,011,200 shares married deal @ $1.70
12,546,100 shares married deal @ $1.70

7,367,000 shares married deal @ $1.70

1,000,000 shares married deal @ $1.70

Likely to be Robust Plan which bought. Their stake would now be about 19%.

Robust Plan may sell all its Cordlife Shares to a special purpose vehicle which has not yet been incorporated ("SPV4").
If and when incorporated, SPV4 is intended to be wholly-owned by another special purpose vehicle ("SPV3") which, if and when incorporated, will be wholly-owned by Jiaxing Huiling No. 3 Investment Partnership (Limited Partnership) ("Huiling"). In June 2015, Huiling entered into a non-binding letter of intent with Zhongyuan Union Cell & Gene Engineering Corporation Ltd. ("Zhongyuan"), a company listed on the
Shanghai Stock Exchange, pursuant to which Huiling may sell all its shares in SPV3 to Zhongyuan in exchange for shares in the capital of Zhongyuan. Zhongyuan is indirectly held by, and is an associated company of, Vcanland Holding Group Company Limited.
Last edit: 8 years 6 months ago by Kapitan.
The following user(s) said Thank You: Poh

Please Log in or Create an account to join the conversation.

More
8 years 6 months ago #22707 by SWN
Replied by SWN on topic CORDLIFE GROUP
Regret for those who sold off last two days after ex div!

Please Log in or Create an account to join the conversation.

More
8 years 5 months ago - 8 years 5 months ago #22709 by Kapitan
Replied by Kapitan on topic CORDLIFE GROUP
Cord Blood Banking Service Market to Reach US$12.9 Billion by 2022: Grand View Research, Inc.


The global cord blood banking (CBB) service market is expected to reach over USD 12 billion by 2022, growing at an estimated CAGR of around 11% from 2015 to 2022, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapy in disease treatment, and rising prevalence of life threatening genetic disorders.

www.prnewswire.com/news-releases/cord-bl...h-inc-544456142.html
Last edit: 8 years 5 months ago by Kapitan.
The following user(s) said Thank You: Poh

Please Log in or Create an account to join the conversation.

More
8 years 5 months ago #22717 by Dongdaemun
Replied by Dongdaemun on topic CORDLIFE GROUP
No, it wasn't Robust Plan that bought the 33 m at crazy price of $1.70. It was another China investor, Kunlum. Now Kunlum has expressly said it is does not intend to do a GO. This is most unusual declaration from a shareholder which holds only 12.77%, still very far from the trigger point of 30%. Is it because it wants to douse the enthusiasm of the market?



"Based on the Form 3 received by the Company, Kunlum has a shareholding interest in 33,118,300 ordinary shares of the Company, which amounts to approximately 12.77% of the issued share capital of the Company. The Company has also been informed that Kunlum does not currently have any intention to make a general offer for all the shares of the Company."

Please Log in or Create an account to join the conversation.

More
8 years 5 months ago #22726 by Poh
Replied by Poh on topic CORDLIFE GROUP
Don't you guys think Cordlife's valuation is steep at 40X FY2016 expected earnings?

factsetpdf.maybank-ke.com/PDF/CN__384f0d...89616c4a24509fff.pdf

Please Log in or Create an account to join the conversation.

More
8 years 5 months ago #22729 by SWN
Replied by SWN on topic CORDLIFE GROUP
If it is steep why is the China investor willing to pay at $1.70 for 33m shares?

Please Log in or Create an account to join the conversation.

Time to create page: 0.230 seconds
Powered by Kunena Forum
 

We have 959 guests and no members online

rss_2 NextInsight - Latest News